VVOS

Vivos Therapeutics (VVOS)

Vivos Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VVOS

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/06/12	20:30	GlobeNewswire Inc.	Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/05/21	02:04	GlobeNewswire Inc.	Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/05/18	05:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/05/16	03:54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/05/15	05:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/05/15	05:05	GlobeNewswire Inc.	Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/05/14	20:30	GlobeNewswire Inc.	Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/04/09	20:30	GlobeNewswire Inc.	Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/03/29	05:05	GlobeNewswire Inc.	Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/03/28	20:30	GlobeNewswire Inc.	Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/02/15	22:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/02/15	22:00	GlobeNewswire Inc.	Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/02/15	07:42	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/02/06	21:30	GlobeNewswire Inc.	Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/01/08	21:30	GlobeNewswire Inc.	Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/12/11	21:30	GlobeNewswire Inc.	Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/12/04	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/12/02	06:12	Edgar (US Regulatory)	Form 424B1 - Prospectus [Rule 424(b)(1)]	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/12/01	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/12/01	06:03	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/11/29	21:30	GlobeNewswire Inc.	Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/11/23	06:46	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/11/15	06:05	GlobeNewswire Inc.	Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/11/10	06:30	GlobeNewswire Inc.	Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/11/04	06:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/11/03	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/11/03	06:00	GlobeNewswire Inc.	Vivos Therapeutics Closes $4 Million Private Placement	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/10/31	21:00	GlobeNewswire Inc.	Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules	NASDAQ:VVOS	Vivos Therapeutics Inc
2023/10/28	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc